Concepedia

Publication | Open Access

Safety and tolerability of GRF6019 in mild‐to‐moderate Alzheimer's disease dementia

DOIFull Paper Access

15

Citations

41

References

2020

Year

Jonas Hannestad, Katie Koborsi, Vicki Klutzaritz, Whitney Chao, Rebecca D. Ray, Antonio Páez, Sam Jackson, Scott Lohr, Jeffrey L. Cummings, Gary G. Kay,
Alzheimer s & Dementia Translational Research & Clinical Interventions

Abstract

GRF6019 was safe and well tolerated, and patients experienced no cognitive decline and minimal functional decline. These results support further development of GRF6019.

References

YearCitations

Page 1